Vita 34 AG operates in the Health and allied services sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Vita 34 AG with three other
health care providers in Europe:
aciju i Reumatologiju Dr Simo Milosevic
sales of 11.54 million Euro [US$13.58 million]
Institut Stvolovykh Kletok Cheloveka PAO
of RUSSIAN FEDERATION
(835.58 million Russian Rubles [US$10.75 million]
of which 47%
was Project services Genetico), and
Dom Lekarski SA
based in POLAND
(44.76 million Polish New Zlotys [US$11.52 million]
Vita 34 AG reported sales of 20.25 million Euro (US$23.82 million)
December of 2019.
decrease of 0.8%
versus 2018, when the company's sales were 20.41 million Euro.
Contributing to the drop in overall sales was the 97.0% decline
in Other Revenue, from 879,000.00 Euro to 26,000.00 Euro.
However, these declines were partially offset by the increase in sales of
Revenue From Storage (up 2.2% to 14.92 million Euro)
Revenue From Processing/manufacturing (up 7.5% to 5.30 million Euro)